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Arthritis Critically Dependent
on Innate Immune System Players
Disease in these animals is focused specifically on the
joints but stems from autoreactivity to a ubiquitously
expressed antigen, glucose-6-phosphate isomerase
Hong Ji,1,3 Koichiro Ohmura,1,3 Umar Mahmood,4
David M. Lee,2 Frans M.A. Hofhuis,5
Susan A. Boackle,6 Kazue Takahashi,7
V. Michael Holers,6 Mark Walport,8 Craig Gerard,9 (GPI). T and B cells are both required for disease initia-
Alan Ezekowitz,7 Michael C. Carroll,10 tion, but anti-GPI immunoglobulins (Igs), alone, can
Michael Brenner,2 Ralph Weissleder,4 induce arthritis in lymphocyte-deficient recipients.
J. Sjef Verbeek,5 Veronique Duchatelle,11 Here, we show that the arthritogenic Igs act through
Claude Degott,11 Christophe Benoist,1,2,3,12 both Fc receptors (in particular, FcRIII) and the com-
and Diane Mathis1,2,3,12 plement network (C5a). Surprisingly, the alternative
1Section on Immunology and Immunogenetics pathway of complement activation is critical, while
Joslin Diabetes Center classical pathway components are entirely dispens-
2 Division of Rheumatology, Immunology and Allergy able. We suggest that autoimmune disease, even one
Department of Medicine that is organ specific, can occur when mobilization
Brigham and Women’s Hospital and of an adaptive immune response results in runaway
Harvard Medical School activation of the innate response.
Boston, Massachusetts 02215
3 Institut de Ge´ne´tique et de Biologie Mole´culaire Introduction
et Cellulaire (CNRS/INSERM/ULP)
1 rue Laurent Fries Inflammatory arthridites, in particular rheumatoid arthri-
67404 Strasbourg, France tis (RA), are an important health problem. As such, they
4 Center for Molecular Imaging Research have been the focus of intense investigation, but their
Massachusetts General Hospital etiology and pathogenesis remain very controversial (re-
Building 149, 13th Street, #5408 viewed in Arend, 1997). For example, there is no consen-
Charlestown, Massachusetts 02129 sus on what initiates RA—whether it is primarily an auto-
5 Department of Human and Clinical Genetics immune response reflecting an aberrancy in immune
Leiden University Medical Center regulation, an inflammatory response to some microbial
Wassenaarseweg 72, P.O. Box 9503 or mechanical insult, or a combination of the two. There
2300 RA Leiden, The Netherlands is also dispute over the major players in RA pathogene-
6 Department of Rheumatology sis—whether T cells, B cells, other leukocytes, or some
University of Colorado Health Sciences Center combination of them drives disease. Much of the contro-
4200 East 9th Avenue versy probably stems from the fact that RA is quite
Denver, Colorado 80262 heterogeneous, raising the possibility that what has7 Pediatrics Division been classified as one disease entity may actually be a
Massachusetts General Hospital collection of disorders, with similar symptoms resulting
15 Parkman Street
from dissimilar causes and courses. Seemingly more
Boston, Massachusetts 02114
homogeneous are the end-stage effector mechanisms,8 Division of Medicine
whose commonalities include massive recruitment ofImperial College School of Medicine
neutrophils and macrophages, the implication of inflam-Hammersmith Hospital
matory cytokines like tumor necrosis factor (TNF)- andLondon W12 ONN, United Kingdom
interleukin (IL)-1, and the synthesis of a battery of degra-9Pulmonary Division
dative enzymes. It is likely, then, that disparate diseaseChildren’s Hospital, Hunnewell
courses converge into a common route of destruction.300 Longwood Avenue
As far as end-stage effector mechanisms, an impor-10Department of Pathology
tant issue is whether and how Fc receptors (FcRs) andHarvard Medical School
components of the complement network are involved.LMRC 502, 221 Longwood Avenue
Both are obvious candidates for linking upstream initia-Boston, Massachusetts 02215
tion events to downstream effector activities. Several11Service d’Anatomie et de Cytologie Pathologique
lines of evidence have implicated FcRs, in particular IgGHopital Beaujon
binding receptors (FcRs), in RA pathogenesis: FcRIII100 Boulevard du Gal Leclerc
was detected on synovial intima in normal and arthritic92118 Clichy Cedex, France
human joints and on invading macrophages in the latter
(Edwards et al., 1997); an FcRIII gene polymorphism
has been correlated with human RA susceptibility (NietoSummary
et al., 2000); mice lacking FcR (and thereby FcRI,
FcRIII, and FcRI) were not susceptible to arthritis in-K/BxN T cell receptor transgenic mice are a model of
duction upon injection of collagen or adjuvant (Kleinau etinflammatory arthritis, similar to rheumatoid arthritis.
al., 2000; van Lent et al., 2000); and lack of the inhibitory
receptor FcRIIB was found to exacerbate collagen-12Correspondence: cb@joslin.harvard.edu (C.B.), dm@joslin.harvard.
edu (D.M.) induced arthritis (CIA) in susceptible mouse strains
Immunity
158
(Kleinau et al., 2000) or permit its induction in normally the complement network during the effector phase of
inflammatory arthritis. More specifically, we defineresistant strains (Yuasa et al., 1999). The complement
network was initially implicated in human RA, indirectly, FcRIII as the critical IgG receptor, the alternative path-
way as the upstream initiator of complement activation,by the colocalization of C3 fragments with immune com-
plexes in joint tissue (Cooke et al., 1975), and by the and C5a:C5aR-mediated interactions as the down-
stream complement effector.demonstration that complement activity, as well as
early-acting components (C2, C4), is routinely de-
pressed in synovial fluid of patients (reviewed in Zvaifler, Results
1973). More recently, more direct evidence of comple-
ment activation in arthritic joints has been reported (Jose The K/BxN serum-transfer system is highly advanta-
et al., 1990). In murine models of RA, especially CIA, C5 geous for studying the effector mechanisms that link
deficiency has frequently been correlated with disease the production of potentially pathogenic Igs and the
resistance (Wang et al., 1995, 2000), although this has overt development of arthritis. Disease induction in this
not always been the case (Andersson et al., 1991). Thus, system is rapid, robust, and reproducible (Korganow et
there is evidence implicating both FcRs and the comple- al., 1999) and contrasts with most murine models of
ment network in RA. Their potential inputs are numerous. autoimmune disease in being applicable in a number of
Concerning the complement pathway, roles in tissue mouse strains (Ji et al., 2001). This last feature is a
destruction (via C5b-9), in mobilizing inflammatory and particular attraction when screening for the effects of
synovial cells (via C3a, C4a, or C5a), or in promoting diverse natural and engineered mutations.
phagocytosis of immune complexes (through CR1 or
CR3) are all possible (reviewed in Ravetch and Clynes, A Role for FcRs
1998). Concerning FcRs, induction of phagocytosis, re- Given that the arthritogenic activity of K/BxN serum re-
cruitment and activation of neutrophils and synovio- sides solely in the IgG fraction (Korganow et al., 1999),
cytes, and amplification of antigen presentation seem we focused on the role of Fc receptors for this isotype
most probable (reviewed in Ravetch and Clynes, 1998). in serum-induced disease. Both high-affinity, FcRI, and
At this point, it is important to delve more deeply: low-affinity, FcRIII, employ the common  chain, FcR
which particular FcRs and complement components are (as does FcRI). Therefore, as a first look, we evaluated
involved in RA? Where do they intervene in the disease the effect of the FcR null mutation (Takai et al., 1994).
process? What is the relationship between these two Serum from arthritic K/BxN mice was injected into
effector arms? This latter question is of particular inter- FcR/ recipients and control littermates, and diverse
est given the recent suggestion that only one or the other disease parameters were followed over time (Figures
of these arms usually dominates any given inflammatory 1A and 1B). Arthritis arose in all control animals, any
response (Ravetch and Clynes, 1998). heterogeneity almost certainly reflecting their mixed
We have chosen to examine these issues in K/BxN (B6x129/Sv) genetic background. In contrast, there was
no evidence of arthritis in the FcR-deficient animalsT cell receptor (TCR) transgenic (tg) mice, a recently
for any parameter, including histological score.developed model of inflammatory arthritis (Kouskoff et
To assess the relative importance of the two receptorsal., 1996; Korganow et al., 1999; Matsumoto et al., 1999).
for IgG, we evaluated the effect of FcRI- and FcRIIIAll K/BxN animals spontaneously develop an autoim-
null mutations (Hazenbos et al., 1996) (Figures 1A andmune disease with most (although not all) of the clinical,
1B). Lack of FcRI appeared to have no influence onhistological, and immunological features of RA in hu-
arthritis development. All FcRIII-deficient mice suc-mans. The murine disorder, critically dependent on both
cumbed to arthritis, but it was attenuated vis-a`-vis theT and B cells, is joint specific but is initiated, then perpet-
disease in wild-type controls according to all parame-uated, by T, then B, cell autoreactivity to a ubiquitously
ters: the day of onset was delayed, ankle thickeningexpressed antigen, GPI. Strikingly, transfer of serum
was reduced, and histological analysis revealed less(or purified anti-GPI Igs) from arthritic K/BxN mice into
infiltration and cartilage destruction.healthy animals provokes arthritis within days, even
In a separate study (Ji et al., 2001), we tested thewhen the recipients are devoid of lymphocytes. A likely
influence of the inhibitory receptor FcRIIB. Neither thescenario is that GPI:anti-GPI immune complexes (ICs)
FcRIIB null mutation (Takai et al., 1996) on a mixedare the link between the systemic T and B lymphocyte
B6x129/Sv genetic background nor a naturally occurringautoreactivity characteristic of K/BxN mice and the en-
defective FcRIIB allele (Luan et al., 1996) placed on asuing joint-specific destruction. ICs may be differentially
B6 background affected development of K/BxN serum-generated or retained in the joint, where they engage
transferred arthritis.FcRs and/or activate the complement network, setting
In short, Fc receptors are required for efficient induc-off a cascade of events that includes the recruitment
tion of arthritis upon transfer of K/BxN serum. FcRIand activation of inflammatory cells and synoviocytes,
plays no essential role, and FcRII appears not to havemassive production of growth factors and cytokines (in
an inhibitory influence, at least in the genetic contextsparticular TNF- and IL-1), and the synthesis of degrada-
so far examined. Intriguingly, the importance of FcRIII,tive enzymes. The relevance of the K/BxN model to
although clearly evidenced, is markedly less than thathuman RA is supported by a recent report that serum
of the common FcR chain.from almost two-thirds of RA patients contained anti-
GPI antibodies (Abs), absent from serum of normal indi-
viduals or of patients with Lyme arthritis or Sjogren’s A Role for the Complement Network
To address the role of the complement network in K/BxNsyndrome (Schaller et al., 2001).
Here, we establish a critical role for both FcRs and serum-transferred arthritis, we initially focused on C5 for
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Figure 2. Role of the Complement Network
(A) A/J strain mice or a C5-proficient congenic variant was injected
with K/BxN serum and arthritis followed by measuring the increaseFigure 1. Role of Fc Receptors in Arthritis Induced by K/BxN Serum
in ankle thickness. Each curve represents an individual mouse.Transfer
These data represent animals scored in the same experiment and
FcR-deficient and control mice (matched for genetic background) are a subset of those in Figure 3.
were injected with 150 l serum from arthritic K/BxN animals on (B) B6 mice were injected with K/BxN serum (d0, d2) with or without
days 0 and 2. Arthritis was evaluated by measuring clinical index pretreatment with anti-C5 mAb (d2, d0; arrows), and the develop-
and ankle thickening (see Experimental Procedures). ment of arthritis followed as above.
(A) Data from representative experiments, each curve signifying an (C) As in (B), except that the anti-C5 mAb treatment was initiated
individual mouse. at d5, when arthritis was already evident.
(B) Tabulation of the results for six mice of each line. *, very weak
arthritis in FcRIII mice, CI of 0.5 to 1; MaxAT, maximum increase
in ankle thickness (mm). The histological score sums scores from
knee, ankle, and tarsal joints (1, minimum synovial hyperplasia; 2, and an anti-C5 monoclonal antibody (mAb) (Frei et al.,
limited inflammatory infiltration; 3, massive infiltration; 4, massive infil- 1987b).
tration with cartilage and bone destruction); maximum score  12. K/BxN serum was injected into C5-deficient and C5-
sufficient A/J congenic mice, and signs of arthritis were
monitored over time (Figure 2A). Mice lacking C5
two major reasons. First, C5 is pivotal in the complement showed no signs of disease development. Since the C5-
network, both effector pathways leading from it and the deficient strain was a congenic rather than a knockout
three initiating pathways leading into it. Second, the variant, it was necessary to confirm that the lack of
critical reagents needed for such a study were available, response to arthritogenic serum was due to the defec-
tive C5 gene itself and not to some adjacent geneticboth a C5-deficient mouse strain (Gervais et al., 1989)
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Figure 3. The Alternative, Not the Classical, Pathway of Complement Activation Is Involved in K/BxN Serum-Transferred Arthritis
The three initiating pathways leading into C5 and the two effector pathways leading from them are schematized. Tabulated next to a particular
component is the effect of its deficiency, assessed for each case in at least two independent experiments, each with at least two individual
mutant mice. Scoring was as described in Experimental Procedures. Arth. represents the proportion of affected mice, AvAT the average max
ankle swelling. Absence of arthritis corresponds to no clinical signs at all. Blue ovals signify no effect; red ovals reflect significant inhibition.
MBL is shown as half-blue/half-white because an MBP-A deficiency showed no effect, but an MBP-C deficiency has not yet been tested.
The asterisks for C3 and fB indicate very weak disease manifestations.
variation. Therefore, recipients of K/BxN serum were being careful to compare control animals that were the
most closely genetically matched possible. The datatreated with anti-C5 mAb starting from 2 days before
serum injection (Figure 2B). These animals also showed are summarized and oriented within the complement
network in Figure 3; results from representative individ-no signs of disease. Interestingly, anti-C5 mAb treat-
ment could also reverse ongoing disease when injected ual experiments for each mutant strain are presented in
Figure 4A.several days after arthritis onset (Figure 2C).
Thus, the complement pathway is a critical player in Two effector pathways lead from C5 (Figure 3). First,
its cleavage product C5b initiates formation of the mem-K/BxN serum-induced arthritis.
brane attack complex. This pathway was not required
for K/BxN serum-transferred arthritis because a C6 defi-It’s the Alternative Pathway!
Next, we were interested in defining the upstream and ciency did not influence disease progression (Figures 3
and 4). The other C5 cleavage product, C5a, is a potentdownstream pathways responsible for the arthritogeni-
city of K/BxN serum, i.e., the route leading from and into promoter of inflammation, having strong chemotaxic
properties, in particular for neutrophils, as well as aC5. The approach was to monitor the effect of injecting
serum from arthritic K/BxN mice into various genetically plethora of other proinflammatory activities. This ef-
fector pathway was crucial for K/BxN serum-transferredengineered or naturally variant recipients deficient for
a particular complement pathway component, always arthritis, as a null mutation of the C5a receptor (C5aR)
Fc Receptors, Complement, and Arthritis
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Figure 4. Role of Individual Complement
Components
(A) Mice deficient in particular components
of the complement network (and genetically
matched controls) were injected with K/BxN
serum, and the development of arthritis moni-
tored as in Figure 1. Curves signify individual
mice in representative experiments. Data
pooled from multiple experiments appear in
the mini-tables of Figure 3.
(B) Pooled data for mice lacking particular
complement receptors.
(Hopken et al., 1996) completely abrogated disease de- injecting K/BxN serum into mice lacking C4 (Wessels et
al., 1995). These animals developed disease as usual,velopment (Figures 3 and 4). The inhibitory effect of the
C5aR deficiency was as potent as that observed with a arguing against a required role for the classical pathway
(Figures 3 and 4). Given that this result was quite unex-C5 mutation (compare with Figure 2A, top panel): no
clinical or histological abnormalities were detected in pected, we confirmed it by two means. First, we elimi-
nated the possibility that components in the injectedeither case, suggesting that all downstream effector ac-
tivity channels through C5a:C5aR interactions and the serum were complementing the C4 deficiency by trans-
ferring purified IgG, rather than serum, from arthriticinflammation that ensues.
Three initiator pathways lead into C5: the classical K/BxN donors: recipients lacking C4 developed arthritis
with the standard characteristics (data not shown). Sec-and alternative pathways feed directly into C3, while the
mannose binding (MB) lectin pathway channels indi- ond, we tested mice with a null mutation in the gene
encoding an upstream component, C1q (Botto et al.,rectly, certainly by the classical and perhaps by the
alternative pathway, the juncture of the latter being pres- 1998): these animals also became arthritic upon serum
injection (Figures 3 and 4).ently unknown (Schweinle et al., 1989) (Figure 3). The
importance of the classical pathway was assessed by The dispensability of the classical pathway raised the
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question of whether C5 might not be directly cleaved series. Important clues to how these influences might be
integrated could come from delineating when preciselyby proteases derived from invading inflammatory cells,
in particular neutrophils, as has been described in some they impinge on disease progression or from identifying
partial or transient phenotypes in their absence.contexts (Wetsel and Kolb, 1983). If this notion were
true, serum-induced disease would be C3 independent. First, we applied a recently developed in vivo imaging
strategy to visualization of the early stages of serum-This turned out not to be the case: there was a strong
inhibition of arthritis development in C3 null mice (Wes- transferred arthritis. This approach, already applied in
neoplastic settings, relies on protease-activated nearsels et al., 1995) (Figures 3 and 4), although, interestingly,
it was not as profound a block as was seen in C5aR- infra-red fluorescent (NIRF) probes to detect the en-
hanced endocytic/phagocytic and protease activitiesdeficient animals. Unlike the latter strain, the former
showed mild swelling in the occasional paw, as well as characteristic of infiltrating leukocytes (e.g., macro-
phages, dendritic cells, neutrophils) (Weissleder et al.,sporadic histological signs such as synovial hyperplasia
and infiltration. 1999). Fluorochrome tags are conjugated to a protected
graft copolymer at high density, resulting in theirTo assess the contribution of the alternative pathway,
we analyzed disease induction in mice devoid of factor quenching; also incorporated into the copolymer are
recognition sites for cathepsin B; cleavage at these sitesB (Watanabe et al., 2000). Most of these animals did not
develop arthritis upon K/BxN serum transfer, although releases the tags, permitting imaging via external illumi-
nation since both the excitation and emission wave-a few did show some weak clinical and histological
signs—occasional joint swelling, synovial hyperplasia, lengths of the fluorochrome can traverse soft tissue.
Mice were iv-injected with this probe and visualizationand sparse leukocyte infiltrates (Figures 3 and 4). This
distinctly muted response was reminiscent of that ob- performed by NIRF reflectance imaging. As illustrated
in Figure 5A, for a 60-day-old K/BxN TCR tg mouse,served with C3 null animals.
The critical issue then became what activates/ampli- strong fluorescence could be visualized over the ankle
and some of the digits in arthritic animals, while such afies the alternative pathway. A major mechanism is
thought to be amplification via C3b fragment generated signal was not detectable in nonarthritic controls. Clear
fluorescence was also detected, albeit not as strongly,through the classical pathway (Watanabe et al., 2000).
Yet, as detailed above, we have already eliminated any when wild-type mice were injected with K/BxN serum;
a signal could be observed 20 hr after administration ofessential role for classical pathway constituents. An-
other mechanism of activating the alternative pathway serum, at a time when the outward clinical manifesta-
tions were still very discrete (Figure 5B). Only the wild-is via mannose binding protein (MBP) in the MBLectin
pathway, either the MBP-A constituent, MBP-C, or both. type mice showed a response to K/BxN serum injection
in this assay; no significant signal (quantitated in FigureThis has been suggested (Schweinle et al., 1989) but
is controversial, and details of how the MBLectin and 5C) was detected in either the C5- or FcR-deficient
mice. This result indicates that FcRs and the comple-alternative pathways might link remain unknown. Mice
harboring a null mutation at the locus encoding MBP-A ment network are both required for the earliest recruit-
ment of inflammatory cells to the lesion and/or theirhave recently been generated, but an MBP-C mutant is
not yet available. Lack of MBP-A had no apparent effect activation.
Second, we assessed the local consequences of com-on serum-induced disease (Figures 3 and 4), leaving
open the possibilities that MBP-C or either one of the plement activation via immunohistology, testing for
complement deposition by staining joint sections withtwo plays a required role, or that the MBLectin pathway
is not involved. anti-C3 reagents. As shown in Figure 6A, the arthritic
lesion in wild-type recipients of K/BxN serum is accom-A related issue was whether and which complement
receptors (CRs) might be involved in K/BxN serum- panied by C3 deposits in several areas of the joint—in
the area of proliferative synovitis and very strikinglytransferred arthritis. CR1 binds the C3b, iC3b, and C4b
fragments; CR2, the C3d and iC3b fragments; and CR3, aligned along the cartilage surface. These correlate with
IgG deposits at the same sites, evidenced in costainingthe iC3b fragment. These interactions have been impli-
cated in immune adherance of opsonized particles, experiments (Figure 6A). In FcR-deficient mice (Figure
6B), the C3 deposits were largely absent, although inphagocytosis, IC clearance, and signal transduction. As
illustrated in Figure 4B, neither a combined deficiency three of the four animals examined, we noted small
patches of mild but significant complement deposition.in CR1 and CR2 (Molina et al., 1996) nor a deficit in CR3
(Coxon et al., 1996) had a detectable effect on serum- IgG deposits were also present, albeit in reduced
amounts. In C5-deficient mice (Figure 6B), the C3 andinduced disease.
In summary, the critical role of the complement net- IgG deposits were completely absent. The conclusion
from this analysis is that both FcRs and the complementwork in K/BxN serum-transferred arthritis is initiated via
the alternative pathway and effected through C5a:C5aR network are required for cell recruitment/activation
events at the earliest stages of arthritis but that comple-interactions. Factor B, C3, C5, and C5aR all have impor-
tant influences on disease induction, whereas C1q, C4, ment is necessary and at least partially sufficient for the
generation of the molecular aggregates that provokeMBP-A, and C6 and CRs 1, 2, and 3 are all dispensable.
these events.
Integration of the FcR and Complement
Network Influences Discussion
Several scenarios could account for the dual importance
of FcRs and the complement network in K/BxN arthritis, We have exploited the K/BxN serum transfer system to
focus on end-stage effector mechanisms in inflamma-invoking independently required roles or critical roles in
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Figure 5. NIRF Imaging of Inflammation
(A) An arthritic K/BxN TCR tg mouse and a control littermate were injected with quenched NIRF probe. Probe cleavage by inflammatory
cathepsins results in increased fluorescence in the arthritic joint of the K/BxN mouse.
(B) Relative fluorescence intensity 24 hr after transfer of K/BxN serum into wild-type or C5-deficient or FcR-deficient mice.
(C) Average signal intensity (log10 scale) over the ankle area, averaged from three to four mice per group.
tory arthritis. In particular, we addressed the role of FcRs dual requirement lies in the complex and chronic nature
of arthritis, dependent on mobilization of multiple ef-and components of the complement network in linking
the production of potentially pathogenic Igs and the fector cell types, cyto/chemokines, and degradative
processes. It is not yet clear whether the two effectordevelopment of joint lesions. Several important findings
emerged: (1) that both effector mechanisms are required arms provide independent required inputs or whether
they make their essential inputs in series. Also not clearfor serum-transferred arthritis; (2) that the critical role of
FcRs is mediated largely, though perhaps not entirely, is what needed element(s) is (are) uniquely mobilized
through FcRs versus components of the complementthrough FcRIII; (3) that activation of the complement
network is initiated via the alternative pathway, the clas- network.
sical pathway being entirely dispensable; and (4) that
the proinflammatory sequelae of C5a:C5aR interactions FcRs
That the K/BxN serum-transfer system is dependent onare key to the complement pathway’s involvement.
FcRs fits well with past indications in other animal mod-
els of RA and in human RA patients. This study bringsBoth FcRs and the Complement Network
Somewhat surprising is the finding that FcRs and the two important additional findings. First, FcRs play a criti-
cal role during the final effector phase of disease. It wascomplement network are equally indispensable for
K/BxN serum-transferred arthritis. It has been argued possible that FcRs were required for antigen presenta-
tion events associated either with the breakdown ofthat these two effector arms play distinct roles in im-
mune responses, the former primordial in inflammatory tolerance to self-Ags or with the initiation of an anti-self-
Ag immune response that culminated in an inflammatoryreactions elicited by Abs or ICs, the latter in innate reac-
tions to bacterial pathogens and toxins (Ravetch and reaction (Ravetch and Bolland, 2001). This remains an
added possibility in the K/BxN model but is certainlyClynes, 1998). However, it now seems clear that both
arms can have an important function in Ab/IC-induced not the only role. In this context, FcRs appear to be a
link between GPI:anti-GPI complexes and downstreaminflammation (Kohl and Gessner, 1999; Ravetch and Bol-
land, 2001), their relative contributions varying with the inflammatory mechanisms.
Second, we define the dominant FcR as FcRIII. Thisparticular tissue(s) involved and the genetic back-
ground. Anti-GPI-induced arthritis would appear to be receptor is expressed on mast cells, neutrophils, macro-
phages, and NK cells. Its engagement is known to acti-on one end of the spectrum, both effector arms being
absolutely necessary. Perhaps the explanation for this vate mast cells, neutrophils, and macrophages; recruit
Immunity
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Figure 6. C3/IgG Deposits
Ankle cryostat sections from B6 mice (injected a week previously with K/BxN or control serum) were stained with anti-C3 (green) and anti-
IgG (red). Note the deposits, absent in the control mouse, on the cartilage surface (cs) and synovial tissue (syn); ac, articular cavity.
(B) Deposits along the cartilage surface of wild-type or C5-deficient or FcR-deficient mice injected with K/BxN serum (sectioning and staining
as in [A]).
(or tether) neutrophils and macrophages to (at) the site The Complement Network
That the complement network is critical for K/BxN se-of inflammation; induce secretion of TNF-, IL-1, other
cytokines, and chemokines; and induce release of lyso- rum-transferred arthritis is again consistent with existing
data on human RA patients and murine RA models. Newsomal enzymes, oxygen radicals, and vasoactive sub-
stances (Ravetch and Bolland, 2001). These activities here is the definition of the effector pathway leading
from C5. It seems that the membrane attack complex,render FcRIII an (if not the) orchestrator of the Arthus
reaction; they can also be readily integrated into a sce- seeded by C5b, does not play a required role; in contrast,
the anaphylatoxin effects unleashed by C5a:C5aR bind-nario of arthritis development in the K/BxN model, in
keeping with the dominant role of IgG1 (our unpublished ing are critical. These encompass a multitude of activi-
ties: vasopermeation and vasodilation; chemotaxis ofdata). Intriguingly, polymorphisms in the gene encoding
FcRIIIB in humans have recently been tied to RA sus- several cell types—notably, mast cells, neutrophils, and
macrophages; degranulation of basophils and mastceptibility (Nieto et al., 2000).
In the Arthus reaction and in other contexts, signals cells; stimulation of respiratory burst by several cell
types; and induction of inflammatory cyto/chemokinetransmitted through FcRIII are attenuated by FcRII-
mediated signals (reviewed in Ravetch and Bolland, release (Gerard and Gerard, 1994). Given that C3a is
also a by-product of complement network activation via2001). Thus, the lack of influence of FcRII mutations,
null or otherwise (Ji et al., 2001), is somewhat surprising. all three initiating pathways, is upstream of C5a, and is
also an anaphylatoxin with many of the same properties,It is possible that an influence will be observed on a
different genetic background or that this particular in- it is surprising that deficiencies in C5 or C5aR have
such drastic effects. Perhaps the explanation lies in theflammatory reaction is just not sensitive to FcRII-medi-
ated signals, both explanations having precedents (Bol- inability of C3a, and the potent ability of C5a, to attract
neutrophils to inflammatory sites and activate them (Daf-land and Ravetch, 2000; Schiller et al., 2000).
Yet FcRIII seems not to be the whole story in the fern et al., 1995). Neutrophils are among the earliest
participants in the joint lesion provoked by K/BxN serumK/BxN model because the absence of this receptor did
not completely prevent disease, while mice lacking the transfer and, in their absence, no lesion develops (Wipke
and Allen, 2001); we will argue below that they are criticalcommon chain, FcR, were completely resistant. An-
other receptor that depends on the common  chain, not inflammation amplifiers. Consistent with such a role is
the fact that depletion of neutrophils reverses ongoingnecessarily FcRI or FcRI but perhaps a new member of
the FcR family (Davis et al., 2001; Hatzivassiliou et al., disease (Wipke and Allen, 2001), as does mAb blockade
of C5.2001), may play a role.
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Also new is the demonstration that the route of initia- Here, we demonstrate that development of this disease
requires both FcRIII and C5aR. It has also been showntion is the alternative pathway, while the classical path-
way is entirely dispensable. This finding, though initially to need neutrophils (Wipke and Allen, 2001), mast cells
(D.L., C.B., and D.M., unpublished data), and inflamma-surprising, is consistent with the fact that the dominant
isotype of anti-GPI Abs in K/BxN mice is IgG1 (Kouskoff tory cytokines such as IL-1 and TNF- (H.J., K.O., C.B.,
and D.M., unpublished data). These dependencies areet al., 1996) and that a pool of IgG1 anti-GPI mAbs
is capable of inducing arthritis in lymphocyte-deficient highly evocative of the Arthus reaction (Ravetch and
Bolland, 2001; Kohl and Gessner, 1999), so it is temptingrecipients (M. Maccioni et al., submitted), murine IgG1
being very poor at complement activation via the classi- to propose a disease scenario in such a framework.
GPI:anti-GPI complexes accumulate in the joint—in par-cal pathway. In another mouse model of systemic auto-
immunity, the MRL/lpr strain, a mutation of factor B led ticular, immobilized at the cartilage surface (Figure 6
and above), but also in circulation through synovial tis-to a drastic reduction in development of disease, but
the involvement of the classical pathway was not tested, sue (like all tissues [Kouskoff et al., 1996]). On the one
hand, as we have discussed, they may bind and stabilizeand it was assumed that the alternative pathway merely
served to amplify a response initiated via the classical low levels of C3b “ticking over,” aggregate into lattices
at the cartilage surface, and seed assembly of C3 androute (Watanabe et al., 2000). In light of our results, it
is important to experimentally verify this assumption. C5 convertases, thereby initiating the alternative path-
way of complement activation. The major role of theWhat initiates the alternative pathway in the K/BxN
serum-transfer system—a pathway generally thought to C5a that is generated may be to recruit neutrophils,
which would have multiple functions, a critical one beingbe focused on microbial surfaces? The possibility we
favor is that mobilization of the alternative pathway is amplification of a complement activation loop feeding
through the alternative pathway. On the other hand,through formation and stabilization of surface-bound
C3b fragments. C3 circulating in the serum is constitu- GPI:anti-GPI complexes may engage FcRs on cells in
the synovial tissue and, as in the Arthus reaction (Sylves-tively cleaved at low levels into C3a and C3b, in the
latter case revealing a reactive thioester that permits tre and Ravetch, 1996; Zhang et al., 1992), FcRIII en-
gagement on mast cells may permit their almost instan-covalent attachment to proteins in the vicinity. Free C3b
and C3b-decorated proteins are normally of very short taneous recruitment and degranulation. This would be
consistent with many observations of recruitment andhalf-life due to inactivation by factors H and I. However,
C3b can bind to IgG ICs to form C3b2-IgG complexes activation of mast cells in the lesions of RA patients
(e.g., Olsson et al., 2001), with the recent finding that athat will bind to surfaces, cluster into lattices, and sup-
port assembly of C3 and C5 convertases (Vivanco et al., drug that blocks mast cell degranulation suppresses
CIA (Malfait et al., 1999) and with our recent observation1999). Joining in the C3b2-IgG complex is properdin,
whose binding induces the participation of factor B, that mice lacking mast cells are not prone to K/BxN
serum-transferred arthritis (D.L., C.B., D.M., unpub-thereby activating the alternative pathway; properdin
also enhances the C3 convertase activity of the assem- lished data). The combined mobilization of these two
effector arms would lead to massive chronic inflamma-bling complex (Jelezarova et al., 2000; Schwaeble and
Reid, 1999). That neutrophils are the major producers tion and ultimately to joint destruction. Such a series of
events could well take place in other murine arthritisof properdin may explain why C5a:C5aR interactions
are so critical in the K/BxN serum-transfer model (Fig- models known to have a critical B cell component—in
particular, CIA and antigen-induced arthritis. The rele-ures 5B and 5C): C5a has potent neutrophil chemotaxic
and degranulation activities (unlike C3a), and neutro- vance to RA, or to particular subsets of it, begs to be
assessed.phils, by producing properdin (as well as additional C3
and factor B), can strongly amplify complement activa- This scenario reverses our standard view of the rela-
tionship between innate and adaptive immunity. Insteadtion via the alternative pathway (Schwaeble and Reid,
1999). C5a-promoted inflammation would thus amplify of an innate response promoting an adaptive one, as
happens in microbial infections, the potent adaptive re-the deposition and stabilization of C3b2-IgG-GPI com-
plexes; without this amplification, complexes would be sponse to GPI in the K/BxN model recruits and oversti-
mulates the innate immune system. It will be interestingcleared, explaining why no C3-IgG deposits were seen
in the absence of C5. to see how many other autoimmune diseases follow like
scenarios.As mentioned above, involvement of the complement
network in arthritis had generally been assumed to re-
flect the classical pathway of activation. The one excep- Experimental Procedures
tion is juvenile rheumatoid arthritis, where several re-
Miceports have provided evidence for mobilization of the
The following mice were used for serum transfer at 4–5 weeks ofalternative pathway and have argued against the impor-
age: FcR/ (Takai et al., 1994) on a mixed B6x129 background,
tance of the classical (e.g., Aggarwal et al., 2000). It is control: (B6x129P3/J)F2 (both from the Jackson Laboratory [JAX]);
imperative to revisit this issue in other subsets of RA FcRII/ (Takai et al., 1996) on a mixed B6x129 background, con-
trol: (B6x129S3/SvImJ)F2 (JAX); FcRIII/ (Hazenbos et al., 1996)patients, especially with the more performant tools now
on both B6 (N  10 generations) and (B6x129)F2 backgrounds,at our disposal.
control: heterozygous littermates (University Medical Center,
Utrecht); FcRI/ on the Balb/c background (J.S.V., unpublished
Conclusion data), control: age/sex-matched Balb/c; CR1/2/ (Ahearn et al.,
K/BxN serum-induced arthritis is mediated by anti-GPI 1996) and CR3/ (Coxon et al., 1996) on a mixed B6x129 back-
ground, control: (B6x129)F2 (Utrecht); A/J congenic C5-sufficientIgGs (Korganow et al., 1996; Matsumoto et al., 1999).
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(A/JC5) and C5-deficient (A/JC5) mice (Zal et al., 1994) (National and P. Morgan for mAbs or mice; D. Bowman and A. Calderone for
sections; C.H. Tung for synthesizing probes; and J. Hergueux, S.Institute for Medical Research, London); C1q/ (Botto et al., 1998)
on a B6 background (N  10) (Columbia University), control: B6 Johnson, and Q.M. Pham for managing the mouse colony. This work
was supported by grants from the Association pour la Recherche(JAX); factor B-deficient (fB/) (Matsumoto et al., 1997) on a mixed
B6x129 background, control: factor B-positive littermates (Univer- contre la Polyarthrite and the NIH (1R01 AR/AI46580-01 and 5 P30
DK36836-15) to D.M. and C.B. and the NIH to R.W. (P50 CA86355)sity of Colorado); C3/, C4/, C5aR/ (Wessels et al., 1995; Fi-
scher et al., 1996; Hopken et al., 1996) on the B6 background (N  and V.M.H. (RO-1 AI31105). K.O. received a fellowship from the
Uehara Memorial Foundation and D.L. from the Howard Hughes5–7), control: B6 (Harvard Medical School); C6/ (Orren et al., 1989)
on the C3H/He background (University of Wales College of Medi- Medical Institute.
cine), control: C3H/HeJ (JAX); MBP-A/ on a mixed B6x129 back-
ground (A.E., unpublished data), control: parallel bred (B6x129)F1 Received August 2, 2001; revised December 7, 2001.
(Massachusetts General Hospital).
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